Alternol Sensitizes Renal Carcinoma Cells to TRAIL-Induced Apoptosis

• Main Authors: Yu Ren (Author), Xue Wang (Author), Shuaishuai Huang (Author), Yangkai Xu (Author), Guobin Weng (Author), Rui Yu (Author)
• Format: Book
• Published: Frontiers Media S.A., 2021-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Purpose: Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), a member of the TNF family, can selectively induce cancer cell death while sparing normal cells. However, the application of TRAIL-based antitumor therapies has been hindered due to drug resistance. Alternol is a new compound...